EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights.

Read Release →

How Long Does It Take to Get ADOS-2 Certified? Complete Guide for Clinicians

On This Page

As autism prevalence reaches 1 in 31 children and diagnostic wait times for autism evaluations often extend four months or longer at the majority of evaluation centers, the demand for clinicians capable of conducting formal autism assessments has never been higher. For ABA practices, speech-language pathologists, and multidisciplinary clinics, building ADOS-2 competency is one of the most common paths to expanding diagnostic capability—but the timeline and investment required can be a surprise.

This guide covers everything you need to know about ADOS-2 training: what “certification” actually means (and doesn’t mean), the clinical and research training pathways, the full cost breakdown, and realistic timelines from first workshop to confident clinical use. We also explore alternatives that can help your practice build diagnostic capacity faster.

ADOS-2 Training Requirements Overview

One of the most common misconceptions about ADOS-2 is that there is a formal “certification” process. In reality, there is no official ADOS-2 certification credential. The instrument’s publisher, Western Psychological Services (WPS), offers clinical training workshops that prepare clinicians to use the tool, but completing a workshop does not confer a license, certificate, or formal credential in the traditional sense.

What clinicians receive after completing an ADOS-2 workshop is a certificate of completion—documentation that they attended the training and earned continuing education contact hours. Clinical competency, however, is developed through ongoing supervised practice after the workshop, not through the workshop alone.

Prerequisites

ADOS-2 training is designed for experienced professionals with a prior background in autism spectrum disorder and formal clinical assessment. The typical prerequisites include a bachelor’s degree or higher in a relevant field (psychology, speech-language pathology, occupational therapy, medicine, or special education) along with current clinical experience working with individuals with ASD. The tool is intended to be administered and interpreted by clinicians working within their professional scope of practice.

The Clinical Training Path

ADOS-2 clinical training is generally open to professionals with experience in autism assessment, developmental psychology, or clinical diagnostics, such as clinical psychologists, developmental pediatricians, child and adolescent psychiatrists, SLPs, occupational therapists, or other licensed behavioral or developmental health providers who have formal training in child development, psychopathology, or related clinical assessment.

Workshop Format and Providers

The standard ADOS-2 introductory clinical workshop is typically a two-day, in-person or virtual training that covers Modules 1 through 4. Additional time is sometimes offered for providers who want to be trained in the toddler module as well. Several leading institutions offer these workshops throughout the year, such as:

Training Provider Duration Cost Format
WPS (Publisher) 2 days (Modules 1–4) $675/person In-person at select U.S. locations
CHOP (Children’s Hospital of Philadelphia) 2 days (Modules 1–4) or 3 days (+ Toddler Module) $650 (2-day) / $950 (3-day) Virtual
UCSF Autism Center 2 days (Modules 1–4) + optional 1 day (Toddler) $600 (2-day) + $300 (Toddler) Virtual (Zoom)
KU GAIN (University of Kansas) 2–3 days $600 + $300 (Toddler) In-person and virtual
Emory Autism Center 2 days (Modules 1–4) Contact for pricing In-person (Atlanta, GA)

Note: Costs and availability are subject to change. The ADOS-2 Manual must be purchased separately and is not included in workshop fees.

Workshops typically include lecture instruction, video demonstrations of each module being administered, and supervised practice scoring. Upon completion, attendees receive a certificate of completion equivalent to approximately 12–16 continuing education (CE) contact hours, depending on the provider.

What the Workshop Covers

During a standard two-day clinical workshop, participants learn the principles of administering and scoring Modules 1 through 4 of the ADOS-2. The training covers module selection criteria, administration protocols, behavioral coding procedures, and algorithm scoring. Participants practice coding behaviors by watching recorded ADOS-2 administrations and comparing their scores with those of certified trainers. The Toddler Module is typically covered through post-course self-study materials or as an additional third day of training.

The Research Reliability Path

For clinicians and researchers who need to use ADOS-2 in published research or multi-site studies, the bar is significantly higher. Research reliability requires demonstrating that you can administer and score the instrument consistently enough to meet inter-rater agreement standards.

What Research Reliability Requires

After completing the introductory clinical workshop (a mandatory prerequisite), individuals pursuing research reliability attend an advanced research training workshop, typically for an additional two to three days. Following this workshop, candidates must submit video recordings of their own ADOS-2 administrations and achieve an inter-rater agreement threshold of 80% or higher with an established, reliable coder. This process involves multiple rounds of feedback and resubmission for many trainees.

Research reliability training is offered by select institutions, including CHOP, the University of Michigan, and programs affiliated with the ADOS-2 authors. The timeline from the introductory workshop to confirmed research reliability typically ranges from six to twelve months, depending on access to suitable clinical populations for practice and the speed of the video review process.

There is no official ADOS-2 “certification.” Clinicians complete training workshops and develop competency through supervised practice. Research reliability requires additional advanced training and demonstrated inter-rater agreement of 80% or higher.

Full Cost Breakdown: ADOS-2 Training and Materials

Understanding the total investment required for ADOS-2 capability is essential for practice owners and clinical directors planning their diagnostic expansion. The costs extend well beyond the workshop registration fee.

Item Estimated Cost Notes
ADOS-2 Kit (Hand-scored) ~$2,400–$2,800 Includes manual, protocol booklets, stimulus materials, and carrying case.
Clinical Workshop (2-day) $550–$675 Per clinician, does not include manual or kit.
Toddler Module Workshop (1 day) $300–$350 Optional add-on; prerequisite is a clinical workshop.
ADOS-2 Manual (Separate Purchase) ~$140–$175 Required reading before the workshop; not included in the kit at all providers.
Replacement Protocol Booklets ~$70–$90 per pack of 10 Ongoing consumable cost per assessment.
Advanced Research Training $600–$1,200+ Only required if pursuing research reliability.
Clinician Time (Practice Sessions) Varies A minimum of 10 supervised practice administrations is recommended.

Sources: WPS, CHOP, UCSF. Prices reflect 2025 estimates and may vary.

Total estimated investment per clinician for clinical use: $3,500–$4,200+ (including kit, workshop, manual, and initial protocol supplies). This figure does not account for the clinician’s time away from billable activities during training and the three-to-six-month practice period, which represents a significant opportunity cost for most practices.

Realistic Timeline: From Workshop to Clinical Competency

One of the most important questions for practice leaders is not just how long the workshop takes, but how long it takes before a clinician can reliably use ADOS-2 in a clinical setting. The answer is longer than many expect.

The Practical Timeline

Workshop: 2–3 days. The introductory clinical workshop provides foundational knowledge, but it is explicitly described by WPS and all training providers as an “essential step toward competence”—not competence itself.

Supervised practice: 10+ administrations per module. After the workshop, clinicians need to administer ADOS-2 at least ten times for each module used under supervision or with scoring review before they can be considered clinically competent. For clinicians who do not see a high volume of ASD referrals, accumulating these practice sessions can take weeks to months.

Self-study and post-course materials: 10–20+ hours. Workshop providers supply post-course video materials and a Toddler Module guidebook that clinicians are expected to complete independently. This additional self-study solidifies skills but adds to the overall timeline.

Total realistic timeline: 3–6 months from initial workshop attendance to confident, independent clinical use. For research reliability, the timeline extends to 6–12 months or longer.

Alternatives for Building Diagnostic Capability Faster

For ABA practices that want to expand diagnostic services without a six-month onboarding timeline per clinician, there are complementary paths worth considering. These are not replacements for clinical expertise, but they offer different tradeoffs in terms of speed, accessibility, and the type of data they provide.

CARS-2 (Childhood Autism Rating Scale, Second Edition)

CARS-2 is a clinician-completed rating scale that typically takes 20–30 minutes, including both observation and scoring, and requires a significantly shorter training period than the ADOS-2. While it lacks the structured observational depth of ADOS-2, it provides a quicker screening and severity rating and is often used as part of a broader assessment battery. Many practices use the CARS-2 as a more accessible entry point into diagnostic assessment.

Technology-Assisted Diagnostic Tools

The most significant development in reducing barriers to diagnostic services is the emergence of FDA-cleared, technology-assisted assessment tools. The EarliPoint System is the first and only FDA-cleared device that uses eye-tracking biomarkers to aid clinicians in diagnosing and assessing ASD in children aged 16–95 months.

What makes EarliPoint particularly relevant for ABA practices is the dramatically lower staffing barrier. Unlike ADOS-2, which requires a clinician with graduate-level training and months of supervised practice, the EarliPoint assessment can be administered by a trained behavior technician. The assessment itself takes approximately 12 minutes, and the device generates a report with objective, quantitative scores across three clinically aligned indices: social disability, verbal ability (language comprehension), and non-verbal learning.

This does not mean EarliPoint replaces the need for qualified clinical oversight—it is a tool that aids a qualified diagnostician, complementing their clinical judgment with objective biomarker data. But for practices that have behavior technicians on staff and struggle to find enough diagnosticians for the volume of children in need, it represents a viable path to offering accurate diagnostic services in a more time-efficient way.

Training Timeline Comparison

Factor ADOS-2 CARS-2 EarliPoint
Workshop Duration 2–3 days Self-study / brief training Practice-specific onboarding
Time to Competency 3–6 months Weeks Shorter training pathway
Who Administers Trained clinician (graduate-level) Trained clinician Trained behavior technician
Assessment Time 40–60 min + scoring and report writing 20–30 min ~12 min
Data Type Subjective observation Subjective rating scale Objective biomarker (120 data points/sec)
FDA Cleared No No Yes – $510k
Upfront Cost per Clinician $3,500–$4,200+ ~$3.50 per booklet Contact EarliPoint for details

Note: These tools serve different but complementary roles. The strongest diagnostic programs combine multiple methods.

Choosing the Right Path for Your Practice

The best approach to building diagnostic capability depends on your practice’s current staffing, patient population, and strategic goals. Many leading practices are adopting a multi-tool approach—combining the clinical depth of traditional assessments with the speed and objectivity of FDA-cleared technology. This allows them to serve a broader range of patients, reduce wait times, and produce diagnostic reports backed by both clinical observation and quantitative biomarker data.

Frequently Asked Questions

Q: Is there an official ADOS-2 certification?

A: No. There is no formal ADOS-2 certification credential. WPS and other training providers offer clinical workshops that result in a certificate of completion and continuing education hours. Clinical competency is developed through supervised practice after the workshop, and research reliability requires additional advanced training and demonstrated inter-rater agreement.

Q: What prerequisites do I need for ADOS-2 training?

A: You generally need a bachelor’s degree or higher in a relevant clinical field (psychology, speech-language pathology, occupational therapy, medicine, or special education) along with experience working with individuals with ASD. The training is intended for professionals who already have a background in autism assessment and will use the tool within their scope of practice.

Q: How much does ADOS-2 training cost in total?

A: The total investment per clinician is approximately $3,500–$4,200 or more, including the ADOS-2 kit (~$2,400–$2,800), clinical workshop ($550–$675), manual (~$140–$175), and initial protocol supplies. This does not include the clinician’s time away from billable work during training and the three-to-six-month supervised practice period.

Q: Can a behavior technician (RBT) administer ADOS-2?

A: No. ADOS-2 requires administration by a trained clinician with graduate-level education and supervised experience in autism assessment. Behavior technicians cannot administer ADOS-2 independently. However, a trained behavior technician can administer the EarliPoint assessment, which is an FDA-cleared device that aids clinicians in autism diagnosis for children aged 16–95 months.

Q: What’s the fastest way for an ABA practice to start offering diagnostic services?

A: The fastest path is to incorporate FDA-cleared technology-assisted tools like the EarliPoint System, which can be administered by a trained behavior technician. While this does not replace the need for qualified diagnosticians to confirm the diagnosis, it does save time and money by improving the efficiency of your diagnostic service.

Expand your diagnostic capabilities faster — see how EarliPoint works.

Download our guide: Adding Diagnostic Services to Your ABA Practice.

 

Cheryl Tierney, MD, MPH

Chief Medical Officer

Developmental pediatrician, public health advocate, and Chief Medical Officer at EarliPoint Health. Cheryl blends scientific curiosity with real-world passion — as a physician, professor, and mom, she’s committed to turning early autism research into better care and support for families.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Cheryl serves as EarliPoint’s Chief Medical Officer, helping advance early autism research into more accessible care and support for families.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder